Biomerica, Inc. is a developer, manufacturer and marketer of in vitro diagnostic tests for clinical diagnostic, life science research and food safety applications. The company’s product portfolio includes enzyme-linked immunosorbent assays (ELISAs), lateral flow immunoassays, point-of-care devices and specialty reagents designed to aid in the detection and monitoring of gastrointestinal, metabolic and autoimmune conditions. Biomerica’s diagnostics are used by hospitals, clinical and reference laboratories, and research institutions seeking solutions for early disease detection and patient management.
Key offerings from Biomerica include serological tests for celiac disease and gluten intolerance, quantitative assays for colorectal cancer screening markers such as M2-PK, and a range of point-of-care kits for metabolic monitoring. The company also produces food safety test kits capable of detecting allergens and gluten residues in food products, serving the needs of food manufacturers and regulatory agencies. Its proprietary testing platforms are designed to deliver rapid, reliable results with user-friendly workflows suitable for both centralized and decentralized laboratory settings.
Founded in the late 1970s and headquartered in Irvine, California, Biomerica maintains a network of direct sales representatives in the United States as well as partnerships with distributors across Europe, Asia and Latin America. The company pursues regulatory clearances such as CE marking and FDA approvals to support its global market expansion. Biomerica’s manufacturing facilities are configured to meet quality standards including ISO 13485, enabling scalable production of diagnostic kits and reagents.
Biomerica is managed by a leadership team with experience in diagnostics research, regulatory affairs and commercial operations. The company continues to invest in product development and strategic collaborations aimed at broadening its assay pipeline and addressing unmet clinical needs. Through ongoing innovation and a focus on building international distribution channels, Biomerica seeks to strengthen its position in the growing in vitro diagnostics market.
AI Generated. May Contain Errors.
Free BMRA Stock Alerts